New York State Common Retirement Fund
ESPR

New York State Common Retirement Fund’s Esperion Therapeutics ESPR Stock Holding History

New York State Common Retirement Fund’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Hold
63,900
– – ﹤0.01% 2371
2026
Q1 		$175K Hold
63,900
– – ﹤0.01% 2279
2025
Q4 		$236K Buy
63,900
+32,500
+104% +$105K ﹤0.01% 2222
2025
Q3 		$83.2K Hold
31,400
– – ﹤0.01% 2725
2025
Q2 		$30.9K Hold
31,400
– – ﹤0.01% 3058
2025
Q1 		$45.2K Hold
31,400
– – ﹤0.01% 2812
2024
Q4 		$69.1K Hold
31,400
– – ﹤0.01% 2747
2024
Q3 		$51.8K Sell
31,400
-45,100
-59% -$91.1K ﹤0.01% 2854
2024
Q2 		$170K Buy
+76,500
New +$180K ﹤0.01% 2494
2023
Q3 		– Sell
-628
Closed -$873 – 3296
2023
Q2 		$873 Sell
628
-24,400
-97% -$34.1K ﹤0.01% 3323
2023
Q1 		$39.8K Sell
25,028
-20,353
-45% -$105K ﹤0.01% 3038
2022
Q4 		$283K Buy
45,381
+2
+0% +$14 ﹤0.01% 2571
2022
Q3 		$304K Buy
45,379
+14,789
+48% +$102K ﹤0.01% 2581
2022
Q2 		$195K Buy
30,590
+4,161
+16% +$23.6K ﹤0.01% 2813
2022
Q1 		$123K Buy
26,429
+4,500
+21% +$19.3K ﹤0.01% 2973
2021
Q4 		$110K Sell
21,929
-27,646
-56% -$221K ﹤0.01% 3049
2021
Q3 		$597K Buy
49,575
+32
+0.1% +$466 ﹤0.01% 2362
2021
Q2 		$1.05M Sell
49,543
-10,728
-18% -$258K ﹤0.01% 2211
2021
Q1 		$1.69M Hold
60,271
– – ﹤0.01% 1875
2020
Q4 		$1.57M Sell
60,271
-7,797
-11% -$234K ﹤0.01% 1804
2020
Q3 		$2.53M Buy
68,068
+12,500
+22% +$495K ﹤0.01% 1454
2020
Q2 		$2.85M Buy
55,568
+6,150
+12% +$257K ﹤0.01% 1386
2020
Q1 		$1.56M Sell
49,418
-5,679
-10% -$300K ﹤0.01% 1529
2019
Q4 		$3.29M Buy
55,097
+16,997
+45% +$764K ﹤0.01% 1401
2019
Q3 		$1.4M Buy
38,100
+12,500
+49% +$495K ﹤0.01% 1823
2019
Q2 		$1.19M Buy
25,600
+2,400
+10% +$113K ﹤0.01% 1932
2019
Q1 		$931K Sell
23,200
-7,200
-24% -$323K ﹤0.01% 2001
2018
Q4 		$1.4M Sell
30,400
-6,777
-18% -$327K ﹤0.01% 1729
2018
Q3 		$1.65M Hold
37,177
– – ﹤0.01% 1802
2018
Q2 		$1.46M Buy
37,177
+7,550
+25% +$381K ﹤0.01% 1885
2018
Q1 		$2.14M Sell
29,627
-40,645
-58% -$2.98M ﹤0.01% 1586
2017
Q4 		$4.63M Buy
70,272
+54,372
+342% +$2.93M 0.01% 1268
2017
Q3 		$797K Hold
15,900
– – ﹤0.01% 2118
2017
Q2 		$736K Sell
15,900
-1
-0% -$37 ﹤0.01% 2218
2017
Q1 		$561K Buy
15,901
+2,801
+21% +$64.1K ﹤0.01% 2331
2016
Q4 		$164K Hold
13,100
– – ﹤0.01% 2840
2016
Q3 		$181K Hold
13,100
– – ﹤0.01% 2792
2016
Q2 		$129K Hold
13,100
– – ﹤0.01% 2909
2016
Q1 		$222K Hold
13,100
– – ﹤0.01% 2629
2015
Q4 		$292K Hold
13,100
– – ﹤0.01% 2569
2015
Q3 		$309K Sell
13,100
-2,093
-14% -$131K ﹤0.01% 2557
2015
Q2 		$1.24M Buy
15,193
+11,378
+298% +$1.11M ﹤0.01% 2067
2015
Q1 		$353K Buy
+3,815
New +$246K ﹤0.01% 2084

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

New York State Common Retirement Fund's ESPR Position: Q2 2026 in Review

New York State Common Retirement Fund held its Esperion Therapeutics (ESPR) position steady in Q2 2026 at 63,900 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

New York State Common Retirement Fund first reported a position in ESPR in Q1 2015 and has held it in 43 quarters since. The position peaked at $4.63M in Q4 2017. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • New York State Common Retirement Fund held 63,900 shares of Esperion Therapeutics worth $202K as of Q2 2026.
  • New York State Common Retirement Fund left its Esperion Therapeutics share count unchanged in Q2 2026.
  • Esperion Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2371 holding.
  • New York State Common Retirement Fund first reported a position in Esperion Therapeutics in Q1 2015 and has held it in 43 quarters since.
  • New York State Common Retirement Fund's Esperion Therapeutics position peaked at $4.63M in Q4 2017.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.